124 related articles for article (PubMed ID: 6491917)
1. Systematic error associated with apparatus 2 of the USP dissolution test V: Interaction of two tableted prednisone formulations with glass and plastic vessels.
Cox DC; Furman WB
J Pharm Sci; 1984 Aug; 73(8):1125-7. PubMed ID: 6491917
[TBL] [Abstract][Full Text] [Related]
2. Systematic error associated with apparatus 2 of the USP dissolution test II: Effects of deviations in vessel curvature from that of a sphere.
Cox DC; Wells CE; Furman WB; Savage TS; King AC
J Pharm Sci; 1982 Apr; 71(4):395-9. PubMed ID: 7086644
[TBL] [Abstract][Full Text] [Related]
3. Collaborative study of the USP dissolution test for prednisone tablets with Apparatus 2.
Cox DC; Furman WB
J Pharm Sci; 1984 May; 73(5):670-6. PubMed ID: 6737242
[TBL] [Abstract][Full Text] [Related]
4. Dissolution of prednisone tablets in the presence of an arch-shaped fiber optic probe in a USP dissolution testing apparatus 2.
Zhang Y; Bredael G; Armenante PM
J Pharm Sci; 2013 Aug; 102(8):2718-29. PubMed ID: 23861178
[TBL] [Abstract][Full Text] [Related]
5. Systematic error associated with apparatus 2 of the USP dissolution test III: limitations of calibrators and the USP suitability test.
Cox DC; Furman WB; Thornton LK; Moore TW; Jefferson EH
J Pharm Sci; 1983 Aug; 72(8):910-3. PubMed ID: 6620145
[TBL] [Abstract][Full Text] [Related]
6. Automated sampling of in vitro dissolution medium: effect of sampling probes on dissolution rate of prednisone tablets.
Savage TS; Wells CE
J Pharm Sci; 1982 Jun; 71(6):670-3. PubMed ID: 7097531
[TBL] [Abstract][Full Text] [Related]
7. Systematic error associated with apparatus 2 of the USP dissolution test I: Effects of physical alignment of the dissolution apparatus.
Cox DC; Furman WB
J Pharm Sci; 1982 Apr; 71(4):451-2. PubMed ID: 7086657
[No Abstract] [Full Text] [Related]
8. Typical variability in drug dissolution testing: study with USP and FDA calibrator tablets and a marketed drug (glibenclamide) product.
Qureshi SA; McGilveray IJ
Eur J Pharm Sci; 1999 Feb; 7(3):249-58. PubMed ID: 9845813
[TBL] [Abstract][Full Text] [Related]
9. Systematic error associated with apparatus 2 of the USP dissolution test IV: effect of air dissolved in the dissolution medium.
Cox DC; Furman WB; Page DP
J Pharm Sci; 1983 Sep; 72(9):1061-4. PubMed ID: 6631694
[TBL] [Abstract][Full Text] [Related]
10. A better dissolution method for ranitidine tablets USP.
Cappola ML
Pharm Dev Technol; 2001; 6(1):11-7. PubMed ID: 11247270
[TBL] [Abstract][Full Text] [Related]
11. Cause of high variability in drug dissolution testing and its impact on setting tolerances.
Qureshi SA; Shabnam J
Eur J Pharm Sci; 2001 Jan; 12(3):271-6. PubMed ID: 11113646
[TBL] [Abstract][Full Text] [Related]
12. Mechanistic Approach to Understanding the Influence of USP Apparatus I and II on Dissolution Kinetics of Tablets with Different Operating Release Mechanisms.
Lu Z; Fassihi R
AAPS PharmSciTech; 2017 Feb; 18(2):462-472. PubMed ID: 27106916
[TBL] [Abstract][Full Text] [Related]
13. The USP Performance Verification Test, Part I: USP Lot P Prednisone Tablets: quality attributes and experimental variables contributing to dissolution variance.
Deng G; Ashley AJ; Brown WE; Eaton JW; Hauck WW; Kikwai LC; Liddell MR; Manning RG; Munoz JM; Nithyanandan P; Glasgow MJ; Stippler E; Wahab SZ; Williams RL
Pharm Res; 2008 May; 25(5):1100-9. PubMed ID: 18172581
[TBL] [Abstract][Full Text] [Related]
14. Hydrodynamic, mass transfer, and dissolution effects induced by tablet location during dissolution testing.
Bai G; Armenante PM
J Pharm Sci; 2009 Apr; 98(4):1511-31. PubMed ID: 18781589
[TBL] [Abstract][Full Text] [Related]
15. Vibration effects of lab equipment on dissolution testing with USP paddle method.
Gao Z; Thies A; Doub W
J Pharm Sci; 2010 Jan; 99(1):403-12. PubMed ID: 19544371
[TBL] [Abstract][Full Text] [Related]
16. The USP Performance Verification Test, Part II: collaborative study of USP's Lot P Prednisone Tablets.
Glasgow M; Dressman S; Brown W; Foster T; Schuber S; Manning RG; Wahab SZ; Williams RL; Hauck WW
Pharm Res; 2008 May; 25(5):1110-5. PubMed ID: 18172582
[TBL] [Abstract][Full Text] [Related]
17. ADS-12: an automated programmable 12-tablet dissolution testing system.
Cioffi FJ; Martynovych S; Bendrot H
J Pharm Sci; 1979 Oct; 68(10):1280-6. PubMed ID: 512861
[TBL] [Abstract][Full Text] [Related]
18. Hydrodynamic investigation of USP dissolution test apparatus II.
Bai G; Armenante PM; Plank RV; Gentzler M; Ford K; Harmon P
J Pharm Sci; 2007 Sep; 96(9):2327-49. PubMed ID: 17573698
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo bioequivalence of commercial prednisone tablets.
Francisco GE; Honigberg IL; Stewart JT; Kotzan JA; Brown WJ; Schary WL; Pelsor FR; Shah VP
Biopharm Drug Dispos; 1984; 5(4):335-44. PubMed ID: 6525441
[TBL] [Abstract][Full Text] [Related]
20. Effects of vessel geometric irregularity on dissolution test results.
Gao Z; Ahadi S; Moore TW; Doub WH; Westenberger BJ; Buhse LF
J Pharm Sci; 2011 Mar; 100(3):1093-101. PubMed ID: 20803604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
